Exploring the Safety and Efficacy of Direct Oral Anticoagulants (DOACs) in Vulnerable Patient Populations: Brooklyn Hospital Only

May 10, 2024

Target Audience

All pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:

  • Describe the mechanism, dosing, indications, adverse drug reactions of DOACs
  • Evaluate recommendations provided by guidelines including 2023 ACC/AHA/ACCP/HRS Atrial Fibrillation and American Society of Hematology Treatment of VTE or Pulmonary Embolism regarding DOACs usage in vulnerable patient populations
  • Analyze literature utilizing DOACs in individuals with extreme weight, advanced age, or kidney impairment
  • Summarize the safety and efficacy of utilizing DOACs in the vulnerable patient population based on the primary literature
Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
04/24/2024
Course expires: 
04/09/2026
Event starts: 
05/10/2024 - 2:00pm EDT
Event ends: 
05/10/2024 - 3:00pm EDT
Cost:
$0.00
Rating: 
0
ZOOM or Brooklyn Hospital
United States

Pauletta Lazarevskiy, PGY-1 Pharmacy Resident, PharmD.

Pauletta Lazarevskiy graduated from the Arnold and Marie Schwartz College of Pharmacy and Health Sciences at Long Island University in 2023 and is a PGY1 pharmacy resident at The Brooklyn Hospital Center. Starting this July, she will begin her Ambulatory Care PGY-2 at The Brooklyn Hospital Center.

 

ACPE UAN 0042-0000-24-036-L01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

You will need a device that allows you to hear and see the presentation. Some phones may have limited functionality.